Figure 2.

At comparable dosing levels, results of Japanese patients were similar to those of non‐Japanese patients for the median percent change from the baseline in (a) uNTx/Cr and (b) median uNTx/Cr concentrations. Q4W, every 4 weeks; uNTx/Cr, urine N‐telopeptide corrected for creatinine.